Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J B Marks

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Current Opinion in Gastroenterology|April 13, 2011
Defective innate immunity in inflammatory bowel disease: a Crohn's disease exclusivity?Daniel J B Marks
British Journal of Hospital Medicine (London, England : 2005)|November 2, 2011
Core Training: evidence-based medicine for doctors in trainingDaniel J B Marks, Philip J Smith
British Journal of Hospital Medicine (London, England : 2005)|November 26, 2010
Can we justify the cost of information technology in the NHS?Daniel J B Marks, Philip J Smith
Expert Review of Clinical Immunology|September 11, 2010
Atypical mycobacteria: showerheads, anti-TNF therapy and Crohn's diseaseAlka A Desai, Daniel J B Marks
British Journal of Hospital Medicine (London, England : 2005)|August 26, 2014
The dangers of proton pump inhibitor therapyCarina Owen, Daniel J B Marks, Matthew Banks
British Journal of Hospital Medicine (London, England : 2005)|December 8, 2010
Parenteral nutritionPhilip J Smith, Daniel J B Marks, Alastair Forbes
The American Journal of Emergency Medicine|February 14, 2014
Severe alkalosis and hypokalemia with stanozolol misuseAlexander A N Maini, Hector Maxwell-Scott, Daniel J B Marks
Kidney International|October 1, 2015
Acute kidney injury after ChernobylRobert C Cann, Daniel J B Marks, Steven J Hurel, et al.
Rheumatology (Oxford, England)|September 11, 2014
Staphylococcus lugdunensis septic arthritis and epidural abscess in a patient with rheumatoid arthritis receiving anti-tumour necrosis factor therapyAnna M Rose, Joseph Barnett, Stephen Morris-Jones, et al.
Clinical Reviews in Allergy & Immunology|May 14, 2009
Crohn's disease: an immune deficiency stateDaniel J B Marks, Farooq Z Rahman, Gavin W Sewell, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Current Opinion in Gastroenterology|April 13, 2011
Defective innate immunity in inflammatory bowel disease: a Crohn's disease exclusivity?Daniel J B Marks
British Journal of Hospital Medicine (London, England : 2005)|November 2, 2011
Core Training: evidence-based medicine for doctors in trainingDaniel J B Marks, Philip J Smith
British Journal of Hospital Medicine (London, England : 2005)|November 26, 2010
Can we justify the cost of information technology in the NHS?Daniel J B Marks, Philip J Smith
Expert Review of Clinical Immunology|September 11, 2010
Atypical mycobacteria: showerheads, anti-TNF therapy and Crohn's diseaseAlka A Desai, Daniel J B Marks
British Journal of Hospital Medicine (London, England : 2005)|August 26, 2014
The dangers of proton pump inhibitor therapyCarina Owen, Daniel J B Marks, Matthew Banks
British Journal of Hospital Medicine (London, England : 2005)|December 8, 2010
Parenteral nutritionPhilip J Smith, Daniel J B Marks, Alastair Forbes
The American Journal of Emergency Medicine|February 14, 2014
Severe alkalosis and hypokalemia with stanozolol misuseAlexander A N Maini, Hector Maxwell-Scott, Daniel J B Marks
Kidney International|October 1, 2015
Acute kidney injury after ChernobylRobert C Cann, Daniel J B Marks, Steven J Hurel, et al.
Rheumatology (Oxford, England)|September 11, 2014
Staphylococcus lugdunensis septic arthritis and epidural abscess in a patient with rheumatoid arthritis receiving anti-tumour necrosis factor therapyAnna M Rose, Joseph Barnett, Stephen Morris-Jones, et al.
Clinical Reviews in Allergy & Immunology|May 14, 2009
Crohn's disease: an immune deficiency stateDaniel J B Marks, Farooq Z Rahman, Gavin W Sewell, et al.
Pageof 3